Global Patent Case Tracking and Litigation Research Platform

CasLoc is a patent case tracking and research platform covering patent litigation, PTAB proceedings, UPC cases and EPO oppositions. Built for patent attorneys, law firms and IP professionals, it lets you search by party, proceeding number or attorney, filter by filing date, and get free email alerts on new filings and decisions.

Filters

Filing Date

From

Attorney

All Cases Feed

Global Patent Tracker

142 Found <

1 ...

Arbutus Biopharma Corporation v. Moderna, Inc.

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 26-1581

Filing Date 2026-03-30

Cause / Court 35:271 Patent Infringement

View Details

Novartis Pharmaceuticals Corporation vs. Shilpa Pharma, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00886

Filing Date 2026-02-03

Decision Type Other: Fed Circuit mandate

PDF View Details

Novartis Pharmaceuticals Corporation vs. The Regents of the University of Michigan et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01346

Filing Date 2025-03-05

Decision Type Final Written Decision: original

PDF View Details

Novartis Pharmaceuticals Corporation v. MSN Laboratories Private Limited

PATENT LITIGATION Litigation

Status: Litigation Filed

Docket Number 1:25-cv-00081

Filing Date 2025-01-17

Cause / Court 35:271 Patent Infringement

View Details

Novartis Pharmaceuticals Corporation vs. The Regents of the University of Michigan et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01347

Filing Date 2024-08-28

Decision Type Adverse judgment: post-institution

PDF View Details

Novartis Pharmaceuticals Corporation vs. The Regents of the University of Michigan et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01347

Filing Date 2024-03-13

Decision Type Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314; 37 C.F.R. sec. 42.4

PDF View Details

Novartis Pharmaceuticals Corporation vs. The Regents of the University of Michigan et al.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2023-01346

Filing Date 2024-03-13

Decision Type Institution Decision: Granting Institution of Inter Partes Review 35 U.S.C. sec. 314; 37 C.F.R. sec. 42.4

PDF View Details

Novartis Pharmaceuticals Corporation vs. Shilpa Pharma, Inc.

PTAB-DECISIONS Decision

Status: Decided

Proceeding Number IPR2022-00886

Filing Date 2023-09-29

Decision Type JUDGMENT Final Written Decision Dismissing Petitioner’s Motion to Exclude Evidence Denying Petitioner’s Motion for Sanctions Dismissing-in-Part and Denying-in-Part Patent Owner’s Motion to Exclude Evidence Determining All Challenged Claims Unpatentable 35 U.S.C. § 318(a)